Assessment of the role of the LASER in the treatment of recurrent primary varicose veins | ||
| Al-Azhar International Medical Journal | ||
| Volume 2024, Issue 1, January 2024 | ||
| DOI: 10.58675/2682-339X.2232 | ||
| Authors | ||
| Ahmed Khaled Mohamed AbdelSalam; Al-Metwaly Ragab Ibrahim; Reda Othman Abbas | ||
| Department of Vascular Surgery, Faculty of Medicine for boys, Al-Azhar University, Cairo, Egypt | ||
| Abstract | ||
| Background: There has been no research into the use of endovenous methods for the treatment of relapses. For primary great saphenous vein (GSV) varicosities, endovenous laser ablation (EVLA) has an early success rate of 88% to 100%, which is at least comparable to traditional surgical treatment. Reduced postoperative pain, shorter sick periods, a quicker return to normal activities, & improved cosmetic results seem to be some of the benefits of endovenous procedures over more traditional treatment methods. Society appears to save money, particularly in the case of individuals who are gainfully working. Aim of the work: This research is intended to determine whether or not recurring varicose veins can be effectively treated with endo-venous laser ablation. Patients and methods: Fifty individuals who had been previously treated for GSV varicosities were enrolled. All participants gave their informed consent. Details about the patients' demographics, CEAP classification, results from duplex scans, operating procedures, as well as postoperative checks were gathered. A satisfaction survey was given to the individuals. Results: 50 patients were treated using EVLA for recurrent varicose veins. Within three months after EVLA, 1 (2%) patient developed clinical recurrence, while examination after 6-months revealed 3 (6%) recurrencies, and 12-months examination revealed 6 (12%) recurrencies. Older participants, patients with higher BMI, and those with higher CEAP classification were more likely to have higher pain scores, (Coefficient: 0.13, P= | ||
|
Statistics Article View: 14 |
||
